Utilizing Innovative Nanoparticle Technologies To Build A More Sustainable Pharmaceutical Value Chain

Climate change isn’t just an environmental crisis, it’s also a global health crisis. The healthcare sector accounts for nearly 5% of global greenhouse gas emissions—the equivalent of a small country. Patients are also increasingly seeking out treatments that align with their planet-conscious values. In response to this, the pharmaceutical industry is seizing the agenda and identifying new ways to make processes more sustainable. Merck, for example, has set an ambitious goal to achieve carbon neutrality across its operations by 2025. An Open Letter calling for suppliers to commit to joint, minimum climate and sustainability targets and to play their part in decarbonizing the healthcare value chain has also been signed by the CEOs of AstraZeneca, GSK, Merck, Novo Nordisk, Sanofi, Samsung Biologics, and the Chairman of Roche.

By adopting transformative technologies that reduce waste and emissions, the pharma industry can help to forge a greener, healthier future for all. Access the full article to see how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.